AUTL
Autolus Therapeutics
AUTL
AUTL
99 hedge funds and large institutions have $747M invested in Autolus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
2.67% more ownership
Funds ownership: 64% → 66.67% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
99
Holding in Top 10
3
Calls
$1.52M
Puts
$21K
Top Buyers
| 1 | +$19.3M | |
| 2 | +$14.6M | |
| 3 | +$11.4M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$6.98M |
| 5 |
FAM
Fred Alger Management
New York
|
+$5.17M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$11.9M | |
| 3 | -$11.6M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$6.85M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$2.81M |